KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Inventory Average (2016 - 2026)

Eli Lilly filings provide 18 years of Inventory Average readings, the most recent being $14.1 billion for Q1 2026.

  • On a quarterly basis, Inventory Average rose 67.3% to $14.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $14.1 billion, a 67.3% increase, with the full-year FY2025 number at $10.7 billion, up 59.66% from a year prior.
  • Inventory Average hit $14.1 billion in Q1 2026 for Eli Lilly, up from $13.0 billion in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $14.1 billion in Q1 2026 to a low of $3.9 billion in Q3 2022.
  • Median Inventory Average over the past 5 years was $5.9 billion (2024), compared with a mean of $7.0 billion.
  • Biggest five-year swings in Inventory Average: dropped 0.02% in 2022 and later surged 72.27% in 2025.
  • Eli Lilly's Inventory Average stood at $4.1 billion in 2022, then skyrocketed by 31.12% to $5.3 billion in 2023, then skyrocketed by 40.98% to $7.5 billion in 2024, then soared by 72.27% to $13.0 billion in 2025, then grew by 9.06% to $14.1 billion in 2026.
  • The last three reported values for Inventory Average were $14.1 billion (Q1 2026), $13.0 billion (Q4 2025), and $11.6 billion (Q3 2025) per Business Quant data.